Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ISG20 |
| Upstream (Parents) |
|---|
| (<<) ACTA2 → ISG20 |
| (<<) CASP1 → ISG20 |
| (<<) CASP10 → ISG20 |
| (<<) CD274 → ISG20 |
| (<<) CD79A → ISG20 |
| (<<) CORO1A → ISG20 |
| (<<) INPP5D → ISG20 |
| (<<) IRF1 → ISG20 |
| (<<) ITGB7 → ISG20 |
| (<<) MLKL → ISG20 |
| (<<) PLCG2 → ISG20 |
| (<<) PSTPIP1 → ISG20 |
| (<<) PTK2B → ISG20 |
| (<<) PTK7 → ISG20 |
| (<<) SCARF2 → ISG20 |
| (<<) STAT2 → ISG20 |
| (<<) STAT4 → ISG20 |
| (<<) UBE2J1 → ISG20 |
| (<<) UBE2L6 → ISG20 |
| (<<) VAV1 → ISG20 |
| Downstream (Children) |
|---|
| ISG20 → ANGPTL4 (>>) |
| ISG20 → BCL3 (>>) |
| ISG20 → CEACAM1 (>>) |
| ISG20 → DEPDC7 (>>) |
| ISG20 → DUSP5 (>>) |
| ISG20 → GNE (>>) |
| ISG20 → GNG12 (>>) |
| ISG20 → HAS3 (>>) |
| ISG20 → HMGA2 (>>) |
| ISG20 → ICAM2 (>>) |
| ISG20 → IRX2 (>>) |
| ISG20 → KYNU (>>) |
| ISG20 → PARD6G (>>) |
| ISG20 → PARP10 (>>) |
| ISG20 → RHOF (>>) |
| ISG20 → SH2D2A (>>) |
| ISG20 → SOCS1 (>>) |
| ISG20 → WNT10A (>>) |
